Entry |
|
Name |
Desirudin (USAN/INN); Iprivask (TN) |
Formula |
C287H440N80O110S6
|
Exact mass |
6958.9620
|
Mol weight |
6963.44
|
Sequence |
VVYTDCTESG QNLCLCEGSN VCGQGNKCIL GSDGEKNQCV TGEGTPKPQS HNDGDFEEIP EEYLQ (Disulfide bridge: 6-14, 16-28, 22-39) |
Type |
Peptide |
Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01511 Thrombin inhibitor
|
Remark |
|
Efficacy |
Anticoagulant, Thrombin inhibitor |
Comment |
Peptide
Hirudin derivative
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
hsa04610 | Complement and coagulation cascades |
|
Interaction |
|
Structure map |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AE Direct thrombin inhibitors
B01AE01 Desirudin
D03692 Desirudin (USAN/INN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01511 Thrombin inhibitor
D03692 Desirudin
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Serine peptidases
F2
D03692 Desirudin (USAN/INN)
|
Other DBs |
|
LinkDB |
|